Redmile Group, LLC Insider Trading $NLTX Neoleukin Therapeutics, Inc.

Get the latest insider transactions of Redmile Group, LLC. Redmile Group, LLC is 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in VAPOTHERM INC ($VAPO) and in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in Neoleukin Therapeutics, Inc. ($NLTX) and in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in FATE THERAPEUTICS INC ($FATE) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Atreca, Inc. ($BCEL) and 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Allakos Inc. ($ALLK) and 10% Owner in Stoke Therapeutics, Inc. ($STOK) and Director in Shattuck Labs, Inc. ($STTK) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Allovir, Inc. ($ALVR) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in HOOKIPA Pharma Inc. ($HOOK) and 10% Owner in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR).